The patient's ME resolved after he received the second dexamethasone intravitreal implant, and his vision remained stable. He received panretinal photocoagulation several weeks later to try to prevent the ischemic retinopathy from worsening to retinal neovascularization. His right eye remained unaffected during follow-up.
